Biography

Professor Michael Loebinger is a consultant respiratory physician who treats private and NHS patients at Royal Brompton and Harefield hospitals.

He studied at the University of Cambridge where he obtained a first class degree in Medical Sciences. He then moved to the University of Oxford where he completed his clinical training. Following that, he trained in respiratory medicine in London, at a number of hospitals including St Thomas’, Hammersmith, Charing Cross, St Mary’s, and Royal Brompton hospitals.

Professor Loebinger has won young investigator of the year awards from the Royal Society of Medicine, the European Respiratory Society, the British Thoracic Society and the British Association of Lung Research. 

In addition, he has won prestigious awards from the American Thoracic Society, the Medical Research Society and the British Lung Foundation and was awarded Professor of practice at Imperial College London.

Clinical expertise

Professor Michael Loebinger is a respiratory consultant with particular expertise in respiratory infections. These include patients with:

He also has expertise in tuberculosis (TB), is the TB lead for Royal Brompton and Harefield NHS Foundation Trust, and runs TB outpatient clinics at Chelsea and Westminster Hospital. 

He is chair of the British Thoracic Society Infection Special Advisory Group and is co-writing national British Thoracic Society guidelines for both nontuberculous mycobacteria and bronchiectasis.

Research interests

In 2006, Professor Michael Loebinger was awarded a Clinical Research Training Fellowship from the Medical Research Council for research into the use of adult stem cells in lung disease. This research was performed at UCL and led to a PhD, multiple publications and awards and significant media interest.

His current research aims focus on chronic lung infections, in particular: 

  • bronchiectasis
  • pseudomonas
  • non-tuberculosis mycobacterial infections. 

He is currently researching host susceptibility to these infections, in addition to the development of biomarkers and clinical endpoints to assist in their management.

He has helped set up national and European research networks, with funding to produce clinical bronchiectasis databases and is the recipient of several prestigious research grants. He also collaborates with industry and is the principal investigator of multicentre international clinical trials.

Teaching

Professor Michael Loebinger is a professor of practice at Imperial College London. He supervises PhD students and has supervised for an MSc. He accepts multiple medical students for research attachments each year. He has been an Imperial College tutor and is an Imperial College assessor for higher degrees.

He lectures at national and international meetings about his clinical experience and research.

Furthermore, he is involved in public and patient education, speaking at patient days and for the British Lung Foundation.